Skip to main content
SpringerLink
Log in

Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Insulin resistance (IR) and secondary hyperinsulinaemia are major risk factors of atherosclerosis and probably also of related glomerulosclerosis. Angiotensin, converting enzyme inhibitors (ACEI), while improving IR in essential hypertension, do not improve it in patients with chronic renal disease. Thus, the combination of ACEI and low protein diet was evaluated.

Thirty-eight patients with various kidney diseases and mild to moderate impairment of kidney function were included in the study. Thirteen of them suffered from IR. Their dietary protein intake was decreased from ≥1.0 g/kg/d to 0.6–0.7 g/kg/d. Moreover, they were treated by ACEI enalapril at dosages of 2–10 mg/d depending on the absence/presence and severity of hypertension. The patients were followed for 8 months.

No clinically relevant kidney disease progression (KDP) was found. IR patients improved remarkably. IR was examined by the oral glucose tolerance test and glucose, insulin and C-peptide determinations. Their increased plasma triglyceride, VLDL concentrations and proteinuria decreased, HDL concentration increased. Acid-base balance and anaemia did not change.

It is concluded that protein restriction in combination with ACEI treatment improve IR and the associated dyslipoproteinaemia and proteinuria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aurell, M.: ACE inhibition: Antihypertensive treatment of choice in progressive chronic renal failure?Nephrol. Dial. Transpl., 8, 680 (1993).

    CAS  Google Scholar 

  2. Bennett, P. H., Haffner, S., Kasiske, B. L., Keane, W. F., Mogensen, C. E., Parving, H. H., Steffes, M. W., Striker, G. E.: Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the scientific advisory board of the national kidney foundation from an ad hoc committee of the council on diabetes mellitus of the national kidney foundation.Amer. J. Kidney. Dis., 25, 107 (1995).

    CAS  Google Scholar 

  3. Berne, C., Pollare, T., Lithell, H.: Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors.Diabetes Care, 14 (Suppl. 41), 39 (1991).

    PubMed  Google Scholar 

  4. Breyer, J. A., Hunsicker, L. G., Bain, R. P., Lewis, E. J.: Angiotensin converting enzyme inhibition in diabetic nephropathy.Kidney Int., 45 (Suppl. 45), S156 (1994).

    Google Scholar 

  5. Brunner, H. R.: ACE inhibitors in renal disease.Kidney Int., 42, 463 (1992).

    PubMed  CAS  Google Scholar 

  6. Clozel, M., Kuhn, H., Hefti, F.: Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats.Hypertension, 16, 532 (1990).

    PubMed  CAS  Google Scholar 

  7. Diamond, J. R.: Analogoos pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.Kidney Int., 31 (Suppl. 31), S29 (1991).

    Google Scholar 

  8. Dzúrik, R., Hupková, V., Cěrnáček, P., Valovičová, E., Niederland, T. R.: The isolation of an inhibitor of glucose utilization from the serum of uraemic subjects.Clin. Chim. Acta, 46, 77 (1973).

    Article  PubMed  Google Scholar 

  9. Dzúrik, R., Lajdová, I., Spustová, V., Opatný, K. Jr. Pseudouridine excretion in healthy subjects and its accumulation in renal failure.Nephron, 61, 64 (1992).

    PubMed  Google Scholar 

  10. Dzúrik, R., Supstová, V., Janeková, K.: The prevalenceoof insulin resistance in kidney disease patients before the development of renal failure.Nephron, 69, 281 (1995).

    PubMed  Google Scholar 

  11. El Nahas, A. M., Mallick, N. P., Anderson, S.: Prevention of progressive chronic renal failure.Oxford Med., Oxford 1993.

  12. Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, A. M., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., Bevilacqua, S.: Insulin resistance in essential hypertension.N. Engl. J. Med., 317, 350 (1987).

    Article  PubMed  CAS  Google Scholar 

  13. Fluck, R. J., Raine, E. G.: ACE inhibitors in non-diabetic renal disease.Br. Heart J., 72, 46 (1994).

    Google Scholar 

  14. Fouque, D., Laville, M., Boissel, J. P., Chifflet, R., Labeeuw, M., Zech, P. Y.: Controlled low protein diets in chronic renal insufficiency: Meta-analysis.Br. Med. J., 304, 216 (1992).

    Article  CAS  Google Scholar 

  15. Gin, H., Combe, C., Rigalleau, V., Delafaye, C., Aparicio, M.: Effects of low-protein, low-phosphorus diet on metabolic insulin clearance in patients with chronic renal failure.Am. J. Clin. Nutr., 59, 663 (1994).

    PubMed  CAS  Google Scholar 

  16. Heidland, A., Šebeková, K., Teschner, M.: Nutritional management of the uremic patient. In: Suki, W. N., Massry, S. G. (eds). Therapy of Renal Diseases and Related Disorders. 3rd Ed. Kluwer Academic Publishers, Boston 1996.

    Google Scholar 

  17. Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., Striker, G.: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.N. Engl. J. Med., 330, 877 (1994).

    Article  PubMed  CAS  Google Scholar 

  18. Lajdová, I., Spustová, V.: Determination of pseudouridine in serum and urine by high performance liquid chromatography.Biochem. Clin. Bohemoslov., 20, 79 (1991).

    Google Scholar 

  19. Lithell, H. O., Pollare, T., Berne, C.: Insulin sensitivity in newly detected hypertensive patients: Influence of captopril and other antihypertensive agents on insulin sensitivity and related biological parameters.J. Cardiovasc. Pharmacol., 15 (Suppl. 5), S46 (1990).

    Google Scholar 

  20. Mann, J. F. E., Hilgers, K. F., Veelken, R., Geiger, H., Schmieder, R. E., Luft, F. C.: Effect of antihypertensive therapy on the progression of non-diabetic renal disease.Clin. Nephrol., 38 (Suppl. 1), S74 (1992).

    Google Scholar 

  21. Maschio, G.: Protecting the residual renal function: How do ACE inhibitors and calcium antaganists compare?Nephron, 67, 257 (1994).

    PubMed  CAS  Google Scholar 

  22. Mitch, W. E.: Dietary protein restriction in patients with chronic renal failure.Kidney Int., 40, 326 (1991).

    PubMed  CAS  Google Scholar 

  23. Mitch, W. E., Stein, J. H.: The Progressive Nature of Renal Disease. Churchill Livingstone, New York 1992.

    Google Scholar 

  24. Mogensen, C. E.: Renoprotective role of ACE inhibitors in diabetic nephropathy.Br. Heart J., 72 (Suppl. 3), S38 (1994).

    Google Scholar 

  25. Narins, R. G., Cortes, P.: The role of dietary protein restriction in progressive azotemia.N. Engl. J. Med., 330, 929 (1994).

    Article  PubMed  CAS  Google Scholar 

  26. Okša, A., Roland, R., Grejtovská, B., Rácz, O., Spustová, V., Dzúrik, R.: Enalapril has no effect on insulin sensitivity in nephrogenic hypertension.Biochem. Clin. Bohemoslov., 21, 403 (1992).

    Google Scholar 

  27. Okša, A., Gajdoš, M., Fedelešová, V., Dzúrik, R.: Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension.J. Cardiovasc. Pharmacol., 23, 79 (1994).

    Article  PubMed  Google Scholar 

  28. Remuzzi, A., Ruggenenti, P., Mosconi, L., Pata, V., Viberti, G., Remuzzi, G.: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy.J. Nephrol., 6, 36 (1993).

    Google Scholar 

  29. Supstová, V.: Rapid method for the determination of hippurate in biological fluids by high performance liquid chromatography.J. Chromatogr., 487, 440 (1989).

    Google Scholar 

  30. Spustová, V., Cernay, P., Golier, I.: Inhibition of glucose utilization in uremia by hippurate: Liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification.J. Chromatogr., 490, 186 (1989).

    PubMed  Google Scholar 

  31. Ter Wee, P. M., Donker, A. J. M.: Clinical strategies for arresting progression of renal disease.Kidney Int., 42 (Suppl. 38), S114 (1992).

    Google Scholar 

  32. Wiegmann, T. B., Herron, K. G., Chonko, A. M., MacDougall, M. L., Moore, W. V.: Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients.Diabetes, 41, 62 (1992).

    PubMed  CAS  Google Scholar 

  33. Yoshida, Y., Kawamura, T., Ikoma, M., Fogo, A., Ichikawa, I.: Effects of antihypertensive drugs on glomerular morphology.Kidney Int., 36, 626 (1988).

    Google Scholar 

  34. Zeller, K. R.: Low-protein diets in renal disease.Diabetes Care, 14, 856 (1991).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Preventive and Clinical Medicine, Bratislava, Slovakia

    K. Štefíková, V. Spustová, K. Gazdíková, Z. Krivošíková & R. Dzúrik

Authors
  1. K. Štefíková
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Spustová
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Gazdíková
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Z. Krivošíková
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Dzúrik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Štefíková, K., Spustová, V., Gazdíková, K. et al. Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease. International Urology and Nephrology 29, 497–507 (1997). https://doi.org/10.1007/BF02551119

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02551119

Keywords

Search

Navigation